Author name: InterstellarBlends

CARBONYL SCAVENGER

Cytoprotective mechanisms of Carbonyl scavenging drugs in isolated rat hepatocytes Carbonyl –scavenging drugs & protection against Carbonyl stress-associated cell injury. Therapeutic potential of Carbonyl –scavenging carnosine derivative in metabolic disorders High throughput assay for evaluation of reactive Carbonyl scavenging capacity Edaravone inhibits protein Carbonylation by a direct Carbonyl –scavenging mechanism: focus on reactivity, selectivity, and […]

CARBONYL SCAVENGER Read More »

COLD-INDUCIBLE RNA-BINDING PROTEIN (CIRBP) & DNA REPAIR

PARP-1–dependent recruitment of cold-inducible RNA-binding protein promotes double-strand break repair and genome stability Controversial roles of cold‑inducible RNA‑binding protein in human cancer ThermomiR-377-3p-induced Suppression of CIRBP Expression Is Required for Effective Elimination of Cancer Cells and Cancer Stem-like Cells by Hyperthermia The Prognostic Value of DNA Methylation, Post-Translational Modifications and Correlated with Immune Infiltrates in

COLD-INDUCIBLE RNA-BINDING PROTEIN (CIRBP) & DNA REPAIR Read More »

FASTING MIMICKING DIET

Fasting–Mimicking Diet and hormone therapy induce breast cancer regression Fasting–Mimicking Diet reduces HO-1 to promote T cell-mediated tumor cytotoxicity Fasting–Mimicking Diet promotes Ngn3-driven β-cell regeneration to reverse diabetes Fasting–Mimicking Diet plus chemotherapy in breast cancer treatment Fasting–Mimicking Diet modulates microbiota and promotes intestinal regeneration to reduce inflammatory bowel disease pathology Synergistic effect of Fasting–Mimicking Diet

FASTING MIMICKING DIET Read More »

CARBAMYLATION

CARBAMYLATION-derived products: bioactive compounds and potential biomarkers in chronic renal failure and atherosclerosis CARBAMYLATION and antibodies against carbamylated proteins in autoimmunity and other pathologies Protein CARBAMYLATION in kidney disease: pathogenesis and clinical implications Protein CARBAMYLATION and cardiovascular disease Citrullination and CARBAMYLATION in the pathophysiology of rheumatoid arthritis Myeloperoxidase-mediated lipoprotein CARBAMYLATION as a mechanistic pathway for

CARBAMYLATION Read More »

COGNITIVE ENHANCEMENT

  COGNITIVE ENHANCEMENT COGNITIVE ENHANCEMENT: methods, ethics, regulatory challenges COGNITIVE ENHANCEMENT as a treatment for drug addictions Neuroethical issues in COGNITIVE ENHANCEMENT Non-pharmacological COGNITIVE ENHANCEMENT COGNITIVE ENHANCEMENT by drugs in health and disease Sleep for COGNITIVE ENHANCEMENT The likelihood of COGNITIVE ENHANCEMENT COGNITIVE ENHANCEMENT Attitudes toward pharmacological COGNITIVE ENHANCEMENT—a review Ampakines and the threefold path

COGNITIVE ENHANCEMENT Read More »

HALLMARKS OF AGING

Telomerase gene therapy ameliorates the effects of neurodegeneration associated to short telomeres in mice AGING of Immune System Sex-specific components of frailty in C57BL/6 mice Long live the queen, the king and the commoner? Transcript expression differences between old and young in the termite Cryptotermes secundus Ten years of brainage as a neuroimAGING biomarker of

HALLMARKS OF AGING Read More »

PROTEIN CARBONYLATION

PROTEIN CARBONYLATION PROTEIN CARBONYLATION in human diseases PROTEIN CARBONYLATION, cellular dysfunction, and disease progression Cell signaling by PROTEIN CARBONYLATION and deCARBONYLATION PROTEIN CARBONYLATION as a major hallmark of oxidative damage: update of analytical strategies Quantification of PROTEIN CARBONYLATION PROTEIN CARBONYLATION and metabolic control systems Rules governing selective PROTEIN CARBONYLATION PROTEIN CARBONYLATION: avoiding pitfalls in the

PROTEIN CARBONYLATION Read More »

HYPOCRETIN OREXIN

HYPOCRETIN (OREXIN ) deficiency in human narcolepsy HYPOCRETIN (OREXIN ) loss in Parkinson’s disease Neurons containing HYPOCRETIN (OREXIN ) project to multiple neuronal systems Behavioral correlates of activity in identified HYPOCRETIN /OREXIN neurons HYPOCRETIN (OREXIN ) loss in Alzheimer’s disease The HYPOCRETIN /OREXIN system HYPOCRETIN (OREXIN ) cell loss in Parkinson’s disease Release of HYPOCRETIN

HYPOCRETIN OREXIN Read More »

TRYPTOPHAN HYDROXYLASE 2

TRYPTOPHAN HYDROXYLASE –2 controls brain serotonin synthesis TRYPTOPHAN HYDROXYLASE 2 (TPH2 ) gene variants associated with ADHD TRYPTOPHAN HYDROXYLASE –2 (TPH2 ) in disorders of cognitive control and emotion regulation: a perspective Loss-of-function mutation in TRYPTOPHAN HYDROXYLASE –2 identified in unipolar major depression Amygdala responsiveness is modulated by TRYPTOPHAN HYDROXYLASE –2 gene variation TRYPTOPHAN HYDROXYLASE

TRYPTOPHAN HYDROXYLASE 2 Read More »

NEUROPLASTICITY

Harnessing NEUROPLASTICITY for clinical applications NEUROPLASTICITY in children Conceptualizing functional NEUROPLASTICITY Homer2 is necessary for EtOH-induced NEUROPLASTICITY Stress, depression, and NEUROPLASTICITY: a convergence of mechanisms Threoretical aspects of NEUROPLASTICITY Toward a theory of NEUROPLASTICITY Antidepressants and NEUROPLASTICITY Mitochondria and NEUROPLASTICITY Central NEUROPLASTICITY and pathological pain NEUROPLASTICITY subserving motor skill learning NEUROPLASTICITY mediated by altered gene

NEUROPLASTICITY Read More »

Shopping Cart
Scroll to Top